Monitoring of tumor vascular normalization: the key points from basic research to clinical application
Tumor vascular normalization alleviates hypoxia in the tumor microenvironment, reduces the
degree of malignancy, and increases the efficacy of traditional therapy. However, the time …
degree of malignancy, and increases the efficacy of traditional therapy. However, the time …
PET/MRI of central nervous system: current status and future perspective
ZL Yang, LJ Zhang - European radiology, 2016 - Springer
Imaging plays an increasingly important role in the early diagnosis, prognosis prediction and
therapy response evaluation of central nervous system (CNS) diseases. The newly …
therapy response evaluation of central nervous system (CNS) diseases. The newly …
Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
Background Bevacizumab (BEV), a humanized monoclonal antibody, become a currently
important chemotherapeutic option for the patients with recurrent glioma. The aim of this …
important chemotherapeutic option for the patients with recurrent glioma. The aim of this …
Recent update on PET/CT Radiotracers for Imaging Cerebral Glioma
D Kim, SH Lee, HS Hwang, SJ Kim, M Yun - Nuclear Medicine and …, 2024 - Springer
Positron emission tomography/computed tomography (PET/CT) has dramatically altered the
landscape of noninvasive glioma evaluation, offering complementary insights to those …
landscape of noninvasive glioma evaluation, offering complementary insights to those …
The validation path of hypoxia PET imaging: focus on brain tumours
Background: Gliomas are brain tumours arising from the glia, the supportive tissue of the
central nervous system (CNS), and constitute the commonest primary malignant brain …
central nervous system (CNS), and constitute the commonest primary malignant brain …
Clinical Theranostics in Recurrent Gliomas: A Review
AR Hoggarth, S Muthukumar, SM Thomas, J Crowley… - Cancers, 2024 - mdpi.com
Simple Summary This paper discusses the challenges in treating high-grade gliomas,
particularly glioblastomas, which are aggressive brain tumors with high recurrence rates. It …
particularly glioblastomas, which are aggressive brain tumors with high recurrence rates. It …
Usefulness of positron emission tomographic studies for gliomas
K MiyaKe, D Ogawa, M OKaDa… - Neurologia medico …, 2016 - jstage.jst.go.jp
Non-invasive positron emission tomography (PET) enables the measurement of metabolic
and molecular processes with high sensitivity. PET plays a significant role in the diagnosis …
and molecular processes with high sensitivity. PET plays a significant role in the diagnosis …
A comparison of PET tracers in recurrent high-grade gliomas: a systematic review
S Muthukumar, J Darden, J Crowley, M Witcher… - International Journal of …, 2022 - mdpi.com
Humans with high-grade gliomas have a poor prognosis, with a mean survival time of just 12–
18 months for patients who undergo standard-of-care tumor resection and adjuvant therapy …
18 months for patients who undergo standard-of-care tumor resection and adjuvant therapy …
State of the art treatment and surveillance imaging of glioblastomas
S Margiewicz, C Cordova, AS Chi, R Jain - Seminars in Roentgenology, 2018 - Elsevier
Glioblastoma (GBM) is the most common malignant brain tumor in the United States and the
world with about 15,000 and 210,000 new cases diagnosed each year, respectively. 1 For …
world with about 15,000 and 210,000 new cases diagnosed each year, respectively. 1 For …
In silico analysis suggests differential response to bevacizumab and radiation combination therapy in newly diagnosed glioblastoma
Recently, two phase III studies of bevacizumab, an anti-angiogenic, for newly diagnosed
glioblastoma (GBM) patients were released. While they were unable to statistically …
glioblastoma (GBM) patients were released. While they were unable to statistically …